Literature DB >> 10091886

Identification of Mycobacterium shimoidei by molecular techniques: case report and summary of the literature.

B Mayall1, V Gurtler, L Irving, A Marzec, D Leslie.   

Abstract

A 53-year-old woman from Melbourne, Australia, with squamous cell carcinoma of the oesophagus was shown by computed tomography (CT) scan to have a left apical cavity and inflammatory changes in the right lung consistent with aspiration. Acid-fast bacilli isolated from bronchial washings were identified biochemically first as Mycobacterium terrae, but later as M. shimoidei on the basis of 1) restriction fragment analysis and 2) sequencing of polymerase chain reaction (PCR) amplified 16S rDNA. Nine other descriptions of patients with M. shimoidei isolates were collated. The salient feature of isolates considered to be pathogenic was pulmonary cavitation. Most patients had underlying lung disease, including past tuberculosis or malignancy. Six of eight patients died of progressive respiratory illness, although the contribution of M. shimoidei was not always clear, and two patients improved. One patient with the acquired immune-deficiency syndrome (AIDS) died with Salmonella enteritidis and M. shimoidei isolated from blood cultures. One isolate was regarded as a coloniser. There are insufficient clinical or sensitivity data on which to base recommendations for therapy, but a combination of ethambutol, rifabutin and pyrazinamide could be considered.

Entities:  

Mesh:

Year:  1999        PMID: 10091886

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.

Authors:  Vide Popovic; Dragan Arar; Dragica Roso Popovic; Igor Barisic; Marija Tonkic; Irena Peric; Anita Novak; Zana Rubic; Vera Katalinic-Jankovic; Mateja Jankovic Makek; Ivana Goic-Barisic
Journal:  Folia Microbiol (Praha)       Date:  2017-09-14       Impact factor: 2.099

2.  A case of mild pulmonary disease due to Mycobacterium shimoidei with a favorable outcome.

Authors:  Nadia Galizzi; Enrico Tortoli; Andrea Gori; Fulvia Morini; Giuseppe Lapadula
Journal:  J Clin Microbiol       Date:  2013-08-07       Impact factor: 5.948

3.  Mycobacterium shimoidei, a Rare Pulmonary Pathogen, Queensland, Australia.

Authors:  Timothy M Baird; Robyn Carter; Geoffrey Eather; Rachel Thomson
Journal:  Emerg Infect Dis       Date:  2017-11       Impact factor: 6.883

4.  Membranous glomerulonephritis associated with Mycobacterium shimoidei pulmonary infection.

Authors:  Nobuhiro Kanaji; Yoshio Kushida; Shuji Bandoh; Tomoya Ishii; Reiji Haba; Akira Tadokoro; Naoki Watanabe; Takayuki Takahama; Nobuyuki Kita; Hiroaki Dobashi; Takuya Matsunaga
Journal:  Am J Case Rep       Date:  2013-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.